Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 17 04:00PM ET
24.00
Dollar change
-0.40
Percentage change
-1.64
%
IndexS&P 500 P/E17.39 EPS (ttm)1.38 Insider Own0.18% Shs Outstand5.68B Perf Week-1.23%
Market Cap136.45B Forward P/E7.78 EPS next Y3.09 Insider Trans0.17% Shs Float5.67B Perf Month5.12%
Income7.87B PEG- EPS next Q0.57 Inst Own67.07% Short Float1.85% Perf Quarter-8.78%
Sales62.46B P/S2.18 EPS this Y-3.50% Inst Trans0.76% Short Ratio2.00 Perf Half Y-5.40%
Book/sh15.89 P/B1.51 EPS next Y2.83% ROA3.67% Short Interest104.99M Perf Year-13.20%
Cash/sh3.05 P/C7.88 EPS next 5Y-0.27% ROE8.62% 52W Range20.92 - 31.54 Perf YTD-9.54%
Dividend Est.1.71 (7.11%) P/FCF12.16 EPS past 5Y-13.25% ROIC5.32% 52W High-23.91% Beta0.54
Dividend TTM1.70 (7.08%) Quick Ratio0.96 Sales past 5Y9.10% Gross Margin66.93% 52W Low14.75% ATR (14)0.49
Dividend Ex-DateMay 09, 2025 Current Ratio1.26 EPS Y/Y TTM2770.58% Oper. Margin27.53% RSI (14)53.71 Volatility1.38% 1.35%
Employees81000 Debt/Eq0.69 Sales Y/Y TTM13.38% Profit Margin12.59% Recom2.44 Target Price28.11
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q-5.13% Payout119.94% Rel Volume0.77 Prev Close24.40
Sales Surprise-1.47% EPS Surprise38.22% Sales Q/Q-7.82% EarningsApr 29 BMO Avg Volume52.40M Price24.00
SMA201.30% SMA503.78% SMA200-7.71% Trades Volume40,408,780 Change-1.64%
Date Action Analyst Rating Change Price Target Change
Apr-22-25Initiated Cantor Fitzgerald Neutral $24
Dec-10-24Resumed BofA Securities Neutral $29
Nov-15-24Initiated Wolfe Research Underperform $25
Oct-25-24Resumed Citigroup Neutral $30
Oct-17-24Initiated Bernstein Mkt Perform $32
Aug-07-24Upgrade Daiwa Securities Neutral → Outperform
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Today 07:00AM
Jun-17-25 07:34PM
05:16PM
02:39PM
11:20AM
11:18AM Loading…
11:18AM
10:32AM
10:12AM
09:40AM
09:02AM
04:49AM
Jun-16-25 11:40AM
11:20AM
09:29AM
09:06AM
09:00AM Loading…
09:00AM
Jun-15-25 05:47AM
Jun-13-25 12:45PM
11:30AM
09:15AM
Jun-12-25 10:21AM
08:15AM
05:00AM
Jun-11-25 11:27AM
10:57AM
10:20AM
09:40AM
Jun-10-25 04:10PM
10:50AM
10:23AM
10:19AM Loading…
10:19AM
10:10AM
08:18AM
Jun-09-25 07:12PM
06:09PM
12:50PM
10:18AM
09:00AM
08:33AM
Jun-08-25 06:35AM
Jun-07-25 09:00AM
06:30AM
05:59AM
05:23AM
Jun-06-25 04:16PM
09:40AM
09:16AM
07:00AM
05:15AM
04:00AM
01:30AM
Jun-05-25 12:10PM
09:10AM
09:10AM
03:34AM
03:06AM
Jun-04-25 04:57AM
04:47AM
Jun-03-25 12:16PM
12:11PM
10:24AM
07:59AM
03:06AM
Jun-02-25 09:00PM
01:38PM
11:39AM
10:00AM
09:38AM
08:46AM
08:07AM
Jun-01-25 11:34PM
09:15AM
May-31-25 08:00AM
04:00AM
May-30-25 03:10PM
11:42AM
08:00AM
May-29-25 11:29PM
11:40AM
11:30AM
10:29AM
09:40AM
09:18AM
09:05AM
May-28-25 08:00AM
May-27-25 10:00AM
09:00AM
05:21AM
May-26-25 09:41AM
09:38AM
09:16AM
May-24-25 03:00PM
08:45AM
05:00AM
04:51AM
04:11AM
May-23-25 05:10PM
04:09PM
04:02PM
03:21PM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelFormer OfficerMay 23 '25Proposed Sale23.0959,7811,380,632May 23 10:54 AM
Dolsten MikaelFormer OfficerMay 05 '25Proposed Sale23.8755,0001,312,736May 05 04:45 PM
DAMICO JENNIFER B.SVP & ControllerMar 04 '25Sale25.932,50064,82511,850Mar 06 01:57 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27 '25Option Exercise31.3122,416701,84531,063Mar 03 05:39 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27 '25Option Exercise31.3185,1822,667,048250,866Mar 03 05:38 PM
SAHNI PAYALExecutive Vice PresidentFeb 27 '25Option Exercise31.3119,054596,58144,242Mar 03 05:38 PM
McDermott MichaelExecutive Vice PresidentFeb 27 '25Option Exercise31.3148,4191,515,999122,413Mar 03 05:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27 '25Option Exercise31.31156,9144,912,977309,790Mar 03 05:37 PM
Fonseca LidiaExecutive Vice PresidentFeb 27 '25Option Exercise31.3172,6292,274,014111,534Mar 03 05:36 PM
BOURLA ALBERTChairman & CEOFeb 27 '25Option Exercise31.31582,82318,248,188931,744Mar 03 05:36 PM
McDermott MichaelExecutive Vice PresidentFeb 22 '25Option Exercise30.1711,125335,64187,636Feb 25 07:38 PM
DAMICO JENNIFER B.SVP & ControllerFeb 22 '25Option Exercise30.178,741263,71617,602Feb 25 07:38 PM
BOURLA ALBERTChairman & CEOFeb 22 '25Option Exercise30.17238,3997,192,498570,436Feb 25 07:06 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 22 '25Option Exercise30.1785,8242,589,310232,775Feb 25 07:05 PM
SAHNI PAYALExecutive Vice PresidentFeb 22 '25Option Exercise30.1712,714383,58137,099Feb 25 07:04 PM
SUSMAN SALLYExecutive Vice PresidentFeb 22 '25Option Exercise30.1763,5731,917,997225,184Feb 25 07:02 PM
BOSHOFF CHRISTOFFELPresident, R&DFeb 22 '25Option Exercise30.178,741263,716159,085Feb 25 06:58 PM
BLAYLOCK RONALD EDirectorFeb 13 '25Buy25.6519,457499,07227,707Feb 14 05:16 PM
Gottlieb ScottDirectorOct 30 '24Buy28.241,00028,24010,000Oct 31 04:06 PM
DAMICO JENNIFER B.SVP & ControllerAug 13 '24Sale28.665,154147,7148,582Aug 14 03:47 PM